Nvidia investors took a steep dive recently, as it got engulfed in the recent tariffs turbulence. Read why I maintain my buy ...

The path ahead for tariffs is still a wild card for the Fed with respect to inflation’s path. The market continues to ...

Utah Medical Products' stock decline is overblown, as margins remain intact and the balance sheet has substantial assets.

Explore VERV's promising gene-editing therapies, including VERVE-102 with a 69% LDL-C reduction. Click here to read my most ...

FS KKR Capital trades at a 21% NAV discount, offering value for passive income investors. Click here to read an analysis of ...

GXO Logistics faces macroeconomic pressures, integration challenges and soft 2025 growth. Read more about the company's ...

Nvidia Corporation navigates trade uncertainties amid fluctuating tariffs and AI regulations. Learn why it remains a Buy. Click for my NVDA stock update.

MSTY is a single stock covered call ETF tied to Strategy, which is heavily linked to Bitcoin. Find out why I'm bearish on the ...

The outlook for the S&P 500's dividends in future quarters generally trended for the worse over the past four weeks since our ...

Discover how we navigated surprises in Q1, updated our portfolio strategy, and reviewed performance, including insights on ...

Nvidia Corp. faces challenges, with new U.S. licensing rules cutting $5.5B from quarterly sales and China's demand declining.

Republic Services outperforms with recession-resistant cash flows, strategic investments, and robust growth. Read more about ...